February 27, 2008 - diaDexus Inc. said the FDA cleared for marketing a new automated version of its proprietary PLAC Test. an automated immunoassay designed to run on common existing laboratory equipment, including clinical chemistry analyzers from Hitachi, Roche/Hitachi, and Olympus, expanding the number of clinical labs and physician offices that are able to offer the PLAC Test.

February 27, 2008 - Corgenix Medical Corp. received notification of European Patent Office (EPO) approval for technology to which Corgenix holds exclusive worldwide licensing rights.

McMaster University (McMaster) of Hamilton, Ontario, is the owner of the patent covering the aspirin resistance measurement method. Corgenix has licensed this technology from McMaster and is presently developing products to capitalize on the European protected technology. The patented technology is also related to Corgenix� AspirinWorks test kit, which received FDA clearance in 2007.

February 27, 2008 - ATS Medical Inc. released initial clinical results of stand-alone ablation procedures and an overall expansion into the stand-alone market, using the ATS CryoMaze product line.

February 27, 2008 - The Center for Connected Health, a division of Partners HealthCare and EMC Corp. will study how EMC’s employees diagnosed with hypertension can better manage their health through proactive monitoring and education, marking the first company to participate in SmartBeat, designed by the center.

February 27, 2008 - Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the CONFIENT implantable cardioverter defibrillator (ICD), the LIVIAN cardiac resynchronization therapy defibrillator (CRT-D) and an upgraded LATITUDE Patient Management System.

February 26, 2008 - Microsoft Corp. released at HIMSS 2008 its Patient Safety Screening Tool (PSST), a software-based solution designed to help identify potential adverse events that occur during hospitalization, featuring a set of indicators that provide information on potential in-hospital complications following surgeries and medical procedures.

The enhanced Xcelera solution. The integrated multimodality solution reportedly provides one access point for all relevant cardiology information, such as cardiovascular ultrasound, CT, MR, nuclear medicine, ECGs and electrophysiology recording signals, as well as long-term storage and enterprise distribution of multimedia studies.

Philips offers the Panorama HFO, Achieva 1.5T A-series, Achieva 3.0T X-series and one of the only 1.5T to 3.0T rampable magnet, the Achieva XR. All Philips MRI systems can take advantage of the complete clinical solutions for cardiac MR with the Elite Clinical Cardiac Solution, said Philips.

The Precedence SPECT/CT reportedly unites multislice CT with a flexible gamma camera. The CardioMD is a compact, fixed 90-degree nuclear cardiology camera that offers attenuation correction technology with clinical validation and truncation compensation, said the company. Astonish is an advanced reconstruction algorithm designed to help users to improve image quality and reduce cardiac acquisition times.

Philips' Essence technology is a combination of X-ray tube, detector system and reconstruction design elements designed to improve image quality of CT exams.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now